Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction.
Kohler
H P
HP
Grant
P J
PJ
D019943:Amino Acid Substitution; D000933:Antifibrinolytic Agents / Q000032:analysis; D005176:Factor XIII / Q000235:genetics*; D015956:Factor XIIa / Q000032:analysis; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology* / Q000235:genetics; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis / Q000235:genetics; D017354:Point Mutation; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology*; D010959:Tissue Plasminogen Activator / Q000032:analysis; D044465:White People / Q000235:genetics
D000933:Antifibrinolytic Agents; D017395:Plasminogen Activator Inhibitor 1; D005176:Factor XIII; D015956:Factor XIIa; D010959:Tissue Plasminogen Activator